(IBDS) iShares iBonds Dec 2027 - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US46435UAA97

Corporate Bonds, 2027 Maturity, Investment-Grade

Description: IBDS iShares iBonds Dec 2027

The iShares iBonds Dec2027 Term Corporate ETF (IBDS) is an exchange-traded fund that tracks a specific index of U.S. dollar-denominated, investment-grade corporate bonds maturing in 2027. The fund maintains a high level of consistency with its underlying index by investing at least 80% of its assets in the component securities and at least 90% in similar fixed income securities.

From a strategic perspective, IBDS offers a targeted maturity approach, allowing investors to capitalize on a specific segment of the corporate bond market with a defined maturity date. This can be particularly appealing for investors seeking to match their investment horizon with the funds maturity, potentially reducing interest rate risk associated with longer-term or perpetual bonds.

Key performance indicators (KPIs) to monitor for IBDS include its yield to maturity (YTM), which can provide insight into the funds potential return if held until maturity. Additionally, the funds credit quality, as measured by the average credit rating of its holdings, is crucial in assessing the risk of default. The funds duration, a measure of its sensitivity to interest rate changes, is also an important metric, although it will naturally decrease as the fund approaches its maturity date in 2027. Investors should also keep an eye on the funds expense ratio and tracking error relative to its underlying index to ensure that costs are minimized and that the fund is effectively mirroring its target index.

Given the current market conditions, its essential to evaluate IBDS within the context of a broader fixed income strategy, considering factors such as interest rate expectations, credit spreads, and overall economic outlook. As a targeted maturity fund, IBDS can serve as a valuable component in a diversified investment portfolio, offering a relatively predictable income stream and return of principal at maturity, assuming the underlying bonds are held to maturity and do not default.

IBDS ETF Overview

Market Cap in USD 3,291m
Category Target Maturity
TER 0.10%
IPO / Inception 2017-09-12

IBDS ETF Ratings

Growth Rating 59.3%
Fundamental -
Dividend Rating 72.1%
Return 12m vs S&P 500 -12.0%
Analyst Rating -

IBDS Dividends

Dividend Yield 12m 4.42%
Yield on Cost 5y 4.60%
Annual Growth 5y 7.44%
Payout Consistency 95.1%
Payout Ratio %

IBDS Growth Ratios

Growth Correlation 3m 97.7%
Growth Correlation 12m 95.1%
Growth Correlation 5y 17.7%
CAGR 5y 5.57%
CAGR/Max DD 3y 1.62
CAGR/Mean DD 3y 14.16
Sharpe Ratio 12m -2.15
Alpha 0.02
Beta 0.973
Volatility 1.51%
Current Volume 732.8k
Average Volume 20d 631.1k
Stop Loss 23.6 (-3%)
Signal 0.73

What is the price of IBDS shares?

As of September 18, 2025, the stock is trading at USD 24.33 with a total of 732,786 shares traded.
Over the past week, the price has changed by +0.12%, over one month by +0.69%, over three months by +1.87% and over the past year by +4.31%.

Is iShares iBonds Dec 2027 a good stock to buy?

Partly, yes. Based on ValueRay´s Analyses, iShares iBonds Dec 2027 (NYSE ARCA:IBDS) is currently (September 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 59.25 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IBDS is around 22.96 USD . This means that IBDS is currently overvalued and has a potential downside of -5.63%.

Is IBDS a buy, sell or hold?

iShares iBonds Dec 2027 has no consensus analysts rating.

What are the forecasts/targets for the IBDS price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 25.9 6.3%

Last update: 2025-09-05 04:46

IBDS Fundamental Data Overview

Market Cap USD = 3.29b (3.29b USD * 1.0 USD.USD)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 USD
Beta = 0.62
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 3.29b USD (3.29b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 3.29b)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 3.29b / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default)
NOPAT = 0.0 (EBIT 0.0, no tax applied on loss)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(3.29b)/V(0.0) * Re(9.60%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 9.60% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)

Additional Sources for IBDS ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle